Timing and Outcomes of Noninvasive Ventilation in 307 ARDS COVID-19 Patients: An Observational Study in an Italian Third Level COVID-19 Hospital
Authors:
- Nardi TetajNTNardi Tetaj
- Pierluca PiselliPPPierluca Piselli
- Sara ZitoSZSara Zito
- Giada De AngelisGAGiada De Angelis
- Maria Cristina MariniMMMaria Cristina Marini
- Dorotea RubinoDRDorotea Rubino
- Ilaria GavianoIGIlaria Gaviano
- Maria Vittoria AntonicaMAMaria Vittoria Antonica
- Elisabetta AgostiniEAElisabetta Agostini
- Candido PorcelliCPCandido Porcelli
- Giulia Valeria StaziGSGiulia Valeria Stazi
- Gabriele GarottoGGGabriele Garotto
Open Access
Abstract
Background and Objectives: Background: Coronavirus disease 2019 (COVID-19) is a novel cause of Acute Respiratory Distress Syndrome (ARDS). Noninvasive ventilation (NIV) is widely used in patients with ARDS across several etiologies. Indeed, with the increase of ARDS cases due to the COVID-19 pandemic, its use has grown significantly in hospital wards. However, there is a lack of evidence to support the efficacy of NIV in patients with COVID-19 ARDS. Materials and Methods: We conducted an observational cohort study including adult ARDS COVID-19 patients admitted in a third level COVID-center in Rome, Italy. The study analyzed the rate of NIV failure defined by the occurrence of orotracheal intubation and/or death within 28 days from starting NIV, its effectiveness, and the associated relative risk of death. The factors associated with the outcomes were identified through logistic regression analysis. Results: During the study period, a total of 942 COVID-19 patients were admitted to our hospital, of which 307 (32.5%) presented with ARDS at hospitalization. During hospitalization 224 (23.8%) were treated with NIV. NIV failure occurred in 84 (37.5%) patients. At 28 days from starting NIV, moderate and severe ARDS had five-fold and twenty-fold independent increased risk of NIV failure (adjusted odds ratio, aOR = 5.01, 95% CI 2.08–12.09, and 19.95, 95% CI 5.31–74.94), respectively, compared to patients with mild ARDS. A total of 128 patients (13.5%) were admitted to the Intensive Care Unit (ICU). At 28-day from ICU admission, intubated COVID-19 patients treated with early NIV had 40% lower mortality (aOR 0.60, 95% CI 0.25–1.46, p = 0.010) compared with patients that underwent orotracheal intubation without prior NIV. Conclusions: These findings show that NIV failure was independently correlated with the severity category of COVID-19 ARDS. The start of NIV in COVID-19 patients with mild ARDS (P/F > 200 mmHg) appears to increase NIV effectiveness and reduce the risk of orotracheal intubation and/or death. Moreover, early NIV (P/F > 200 mmHg) treatment seems to reduce the risk of ICU mortality at 28 days from ICU admission.Keywords
All Related Versions
Funding Information
- Italian Ministry of Health (INMI Lazzaro Spallanzani Ricerca Finalizzata COVID-2020-12371675, Ricerca Corrente on emerging infections (Linea 1))
- Italian Ministry of Health (INMI Lazzaro Spallanzani Ricerca Finalizzata COVID-2020-12371675, Ricerca Corrente on emerging infections (Linea 1))
This publication has 20 references indexed in Scilit:
- Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control studyEuropean Respiratory Journal, 2020
- COVID-19 pneumonia: different respiratory treatments for different phenotypes?Intensive Care Medicine, 2020
- Guidelines on the management of acute respiratory distress syndromeBMJ Open Respiratory Research, 2019
- Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failureEuropean Respiratory Journal, 2017
- Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE StudyAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 CountriesJAMA, 2016
- The Berlin definition of ARDS: an expanded rationale, justification, and supplementary materialIntensive Care Medicine, 2012
- Acute Respiratory Distress SyndromeJAMA, 2012
- Ventilation Strategy Using Low Tidal Volumes, Recruitment Maneuvers, and High Positive End-Expiratory Pressure for Acute Lung Injury and Acute Respiratory Distress SyndromeJAMA, 2008
- Bench-to-bedside review: Microvascular and airspace linkage in ventilator-induced lung injuryCritical Care, 2003